Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CREB-regulated transcription coactivator 1 (CRTC1) is a transcriptional coactivator that integrates multiple intracellular signals, notably cAMP and calcium, to regulate gene expression via its interaction with the cAMP response element-binding protein (CREB)[2][3][4]. It is primarily localized to the nucleus and cytosol, where its activity and localization are regulated by phosphorylation status in response to cellular energy and signaling cues. CRTC1 enhances CREB-mediated transcription, affecting processes like mitochondrial biogenesis, neuronal function, memory formation, and circadian regulation[3][2]. In cancer, CRTC1 can act as a driver when fused to MAML2, forming a potent oncogenic fusion transcript implicated in mucoepidermoid carcinoma[2][3]. Loss or dysregulation of CRTC1 activity is implicated in neurodegenerative diseases like Alzheimer's disease, underscoring its essential role in neural gene expression and survival[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CREB-regulated transcription coactivator 1 (CRTC1).